A Message from Dr. Matt Coffey, Interim President and CEO of Oncolytics Biotech Dear Stakeholders and Interested Parties, It has been just over a month since taking on the role of Interim President and CEO and I wanted t

Source URL: oncolyticsbiotech.com

Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer

Source URL: www.nature.com

• Viruses
• Programmed cell death
• Cell signaling
• Immune system
• Reolysin
• Oncolytics Biotech
• Ras subfamily
• Oncolytic virus
• Apoptosis
• Biology
• Medicine
• Cell biology

Springer[removed]Erkenntnis[removed]:295–316 DOI[removed]s10670[removed]PAUL THAGARD

Source URL: cogsci.uwaterloo.ca

• Ethics
• Coherentism
• Philosophical logic
• Coherence theory of truth
• Testimony
• Paul Thagard
• Truth
• Oncolytics Biotech
• Coherence
• Philosophy
• Theories of truth
• Epistemology

CURRICULUM VITAE[removed])

Source URL: www.metrohealthresearch.org

• Gynecologic Oncology Group
• Endometrial cancer
• Ovarian cancer
• Gynecologic oncology
• Fallopian tube cancer
• Society of Gynecologic Oncologists
• Paclitaxel
• Nicholas J. Vogelzang
• Oncolytics Biotech
• Medicine
• Oncology
• Gynaecological cancer

Active Biotech and Ipsen announce completion of recruitment of tasquinimod clinical phase III study in prostate cancer

Source URL: hugin.info

• Clinical trial
• Ipsen
• Biomarker
• TroVax
• Oncolytics Biotech
• Medicine
• Health
• Prostate cancer

This Week in Virology with Vincent Racaniello, Ph.D. Episode 131: A REOstat for cancer Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove Guest: Brad Thompson, CEO of Oncolytics Biotech

Source URL: www.twiv.tv

• Oncolytic virus
• Biology
• Ras subfamily
• Medicine
• Reolysin
• Viruses
• Oncolytics Biotech
• 9

Published OnlineFirst November 24, 2010; DOI:[removed].CCR[removed]A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer Martijn P. Lolkema, H

Source URL: www.oncolyticsbiotech.com

• Reolysin
• Gemcitabine
• Oncolytics Biotech
• Oncolytic virus
• Reoviridae
• Head and neck cancer
• Cholangiocarcinoma
• Pancreatic cancer
• Nasopharyngeal carcinoma
• Medicine
• Viruses
• Organofluorides

Published OnlineFirst March 9, 2010; DOI:[removed].CAN[removed]Oncolytic Viral Therapy for Prostate Cancer: Efficacy of Reovirus as a Biological Therapeutic Chandini M. Thirukkumaran, Michael J. Nodwell, Kensuke

Source URL: www.oncolyticsbiotech.com

• Oncology
• Cell lines
• Reolysin
• Oncolytic virus
• Oncolytics Biotech
• Prostate cancer
• Ras subfamily
• Reoviridae
• Management of cancer
• Biology
• Medicine
• Viruses

DOI:[removed].CCR[removed]A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer Laura Vidal, Hardev S. Pandha, Timothy A. Yap, et al. Clin Cancer Res 2008;14:[removed]

Source URL: www.oncolyticsbiotech.com

• Carbamates
• Brain tumor
• Radiation oncology
• Prostate cancer
• Reolysin
• Oncolytic virus
• Radiation therapy
• Gemcitabine
• Oncolytics Biotech
• Medicine
• Viruses
• Organofluorides

Oncolytic Reovirus in Canine Mast Cell Tumor Chung Chew Hwang1, Saori Umeki1, Masahito Kubo2, Toshiharu Hayashi2, Hiroshi Shimoda3, Masami Mochizuki4, Ken Maeda3, Kenji Baba5, Hiroko Hiraoka5, Matt Coffey6, Masaru Okuda1

Source URL: www.oncolyticsbiotech.com

• Reolysin
• Oncolytics Biotech
• Ras subfamily
• Oncolytic virus
• Reoviridae
• Head and neck cancer
• Cell culture
• Lymphocyte
• Microfold cell
• Biology
• Viruses
• Medicine